This Week in Biotech: Part 2

This Week in Biotech: Part 2

Filed under: drug treatment news articles

BioCryst is quickly running out of drugs in its pipeline. Placenta-based cell therapy developer Pluristem Therapeutics (Nasdaq: PSTI ) also had a wild week, though much less severe than either Catalyst or BioCryst after an article published by …
Read more on Motley Fool

Cellular Therapy Wave Finally Cresting

Filed under: drug treatment news articles

In this article, we focus on the cellular therapy space, which we define as the “deployment of various stem cell classes for the explicit use in the restoration of a given physiological function in vivo that has been damaged by disease or injury …
Read more on Genetic Engineering News

PropThink: Sizing Up Elagolix – A Blockbuster Drug

Filed under: drug treatment news articles

For the purpose of this article we focused solely on endometriosis. However, we remind investors that Abbott is also studying elagolix in a phase IIa exploratory trial for the treatment of uterine fibroids. In September 2011, Abbott announced it had …
Read more on Reuters